Evidence map›Paper›PMID 40050533›Full record

ArticleCommunications biology2025

Neurophysiological insights into catecholamine-dependent tDCS modulation of cognitive control.

Anna Helin Koyun, Paul Wendiggensen, Veit Roessner, Christian Beste, Ann-Kathrin Stock

Abstract read
In one paragraph

Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna Helin KoyunCognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-5896-3550
Paul WendiggensenCognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0002-7155-1067
Veit RoessnerCognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany.
Christian Beste *Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany. Christian.Beste@ukdd.de.ORCID http://orcid.org/0000-0002-2989-9561
Ann-Kathrin Stock *Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany.ORCID http://orcid.org/0000-0001-7113-4020

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Goal-directed behavior requires resolving both consciously and subconsciously induced response conflicts. Neuronal gain control, which enhances processing efficacy, is crucial for conflict resolution and can be increased through pharmacological or brain stimulation interventions, though it faces inherent physical limits. This study examined the effects of anodal transcranial direct current stimulation (atDCS) and methylphenidate (MPH) on conflict processing. Healthy adults (n = 105) performed a flanker task, with electroencephalography (EEG) used to assess alpha and theta band activity (ABA, TBA). Results showed that combining atDCS with MPH enhanced cognitive control and reduced response conflicts more effectively than atDCS alone, particularly when both conflict types co-occurred. Both atDCS and atDCS + MPH exhibited similar task-induced ABA and TBA modulations in the (pre)supplementary motor area, indicating heightened gain control. Overlapping neuroanatomical effects in mid-superior frontal areas suggest that atDCS and MPH share a common neuronal mechanism of gain control, especially in high-conflict/-demand situations.

Indexed as

CatecholaminesCognitionTranscranial Direct Current StimulationAdultElectroencephalographyFemaleHumansMaleMethylphenidateYoung AdultCatecholaminesMethylphenidate

Identifiers

PMID40050533
PMCPMC11885824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.